Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors

Core Viewpoint - MEDIROM MOTHER Labs Inc. has approved a private placement of new shares to its management team as part of its Series A financing round, valuing the company at JPY 9 billion, with funding expected by the end of October [1] Group 1: Company Background - MOTHER Labs operates as the health tech division within the MEDIROM Group, focusing on health guidance programs through the "Lav" healthcare app and the development of wearable devices [2][10] - The decision to conduct a capital increase aims to enhance rapid decision-making and management structure, with the management team investing to boost business responsibility and growth motivation [2] Group 2: Future Outlook - The capital increase will strengthen MOTHER Labs' capital base, facilitating the development of an upgraded version of the MOTHER Bracelet and establishing systems for product market entry [3] - The MEDIROM Group aims to create new value in the healthcare and wellness sector, driving business growth both domestically and internationally [3]